- March 15, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Surmontil, Tripramine, Trimip
Synonyms :
Class :
Antidepressants and antianxiety drugs; norepinephrine reuptake inhibitors
Brand Name :
Surmontil, Tripramine, Trimip
Synonyms :
Class :
Antidepressants and antianxiety drugs; norepinephrine reuptake inhibitors
Dosage forms & Strengths:
Adult:
Capsule:
25 mg
50 mg
100 mg
when both drugs are combined, there may be an increase in qtc interval
may increase the CNS depressant effect of CNS depressants
it increases the effect of CNS depressants
it increases the toxicity of norepinephrine reuptake inhibitors
it increases the effect of serotonergic agents
Norepinephrine Reuptake Inhibitors increase arrhythmia, causing the effect of dronedarone
anticholinergic agents decrease the efficacy of levosulpride
it increases the effect of Norepinephrine Reuptake Inhibitors
they increase the effect of Norepinephrine Reuptake Inhibitors
anticholinergic agents increase the ulcer-producing effect of potassium citrate
CNS depressants increase the CNS suppression effect of thalidomide
it increases the effect of Norepinephrine Reuptake Inhibitors
It may enhance QTc interval when combined with perphenazine
CNS depressants increase the CNS depressing effect of brexanolone
it increases the concentration of Norepinephrine Reuptake Inhibitors
it increases the toxicity of Norepinephrine Reuptake Inhibitors
norepinephrine reuptake inhibitors decrease the effect of guanethidine
it increases the effect of CNS depressants
it increases the toxicity of serotonergic agents
it increases the effect of CNS depressants
anticholinergic agents increase the toxicity of topiramate
may enhance the QTc-prolonging effect of QT-prolonging Miscellaneous Agents
may enhance the QTc-prolonging effect of QT-prolonging Miscellaneous Agents
may enhance the QTc-prolonging effect of QT-prolonging Miscellaneous Agents
may enhance the QTc-prolonging effect of QT-prolonging Miscellaneous Agents
may enhance the QTc-prolonging effect of QT-prolonging Miscellaneous Agents
QT-prolonging Miscellaneous Agents may enhance the QTc-prolonging effect of Quinolone antibiotics
QT-prolonging Miscellaneous Agents may enhance the QTc-prolonging effect of Quinolone antibiotics
may increase the vasopressor effect
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
when both drugs are combined, there may be an increased risk or severity of QTC prolongation
when used together, entrectinib and trimipramine both increase the QTc interval
osimertinib and trimipramine, when used simultaneously, increase the QTc interval
may enhance the QTc-prolonging effect of QT-prolonging Miscellaneous Agents
may enhance the QTc-prolonging effect of QT-prolonging Miscellaneous Agents
may enhance the QTc-prolonging effect of QT-prolonging Miscellaneous Agents
may enhance the QTc-prolonging effect of QT-prolonging Miscellaneous Agents
may enhance the QTc-prolonging effect of QT-prolonging Miscellaneous Agents
may increase the serotonergic effects
may increase the serotonergic effects
may increase the serotonergic effects
may increase the serotonergic effects
may increase the serotonergic effects
may increase the serotonergic effects
may increase the serotonergic effects
may increase the serotonergic effects
may increase the serotonergic effects
may increase the serotonergic effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
they increase the metabolism of norepinephrine reuptake inhibitors
anticholinergic agents increase the effect of constipation of clozapine
it increases the effect of CNS depressants
it increases the effect of CNS depressants
CNS depressants increase the effect of opioid agonists
it increases the effect of norepinephrine reuptake inhibitors
anticholinergic agents decrease the efficacy of secretin
CNS depressants increase the effect of zolpidem
it increases the toxicity of atropine through an unknown mechanism
Frequency undefined:
Sedation
Fatigue
Dry mouth
Constipation
Blurred vision
Weakness
Lethargy
Headache
Agitation
Insomnia
Nausea
Vomiting
Anxiety
Sweating
Confusion
EPS
Dizziness
Tinnitus
Paresthesia
Orthostatic hypotension
ECG changes
Tachycardia
Incr LFTs
Sexual dysfunction
Rash
Seizure
Trimipramine is contraindicated in patients hypersensitive to the formulation’s active ingredient and other excipients.
Pregnancy consideration:
Category C.
Breastfeeding warnings:
Avoid lactation during the treatment of trimipramine.
Pregnancy category:
Patient information leaflet
Generic Name: trimipramine
Pronounced: tri-mi-prah-mine
Why do we use trimipramine?
Trimipramine treats depression.